Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
HDFC Bank
HDB
$115B
| $922K | ﹤0.01% |
119,732
-414,896
| -78% | -$3.41M |
2013 Q2
1 quarter
|
|
|
MZTI
3077
The Marzetti Company
MZTI
$2.72B
| $922K | ﹤0.01% |
11,773
+7,490
| +175% | +$598K |
2013 Q2
1 quarter
|
|
3078
WEC Energy
WEC
$33.1B
| $921K | ﹤0.01% |
22,805
+8,126
| +55% | +$338K |
2013 Q2
1 quarter
|
|
3079
PUT
Apollo Global Management
APO
$67.3B
| $918K | ﹤0.01% |
32,500
+19,500
| +150% | +$523K |
2013 Q2
1 quarter
|
|
|
TECD
3080
PUT
DELISTED
Tech Data Corp
TECD
| $918K | ﹤0.01% |
18,400
+2,600
| +16% | +$131K |
2013 Q2
1 quarter
|
|
|
RNF
3081
CALL
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
| $917K | ﹤0.01% |
37,400
-21,800
| -37% | -$612K |
2013 Q2
1 quarter
|
|
|
PLL
3082
PUT
DELISTED
PALL CORP
PLL
| $917K | ﹤0.01% |
11,900
+1,300
| +12% | +$93.1K |
2013 Q2
1 quarter
|
|
|
EXAS
3083
CALL
DELISTED
Exact Sciences
EXAS
| $915K | ﹤0.01% |
77,500
+30,500
| +65% | +$391K |
2013 Q2
1 quarter
|
|
|
MWIV
3084
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $915K | ﹤0.01% |
+6,126
| New | +$867K |
2013 Q3
0 quarters
|
|
3085
CALL
Henry Schein
HSIC
$9.46B
| $913K | ﹤0.01% |
22,440
-4,590
| -17% | -$186K |
2013 Q2
1 quarter
|
|
|
TYC
3086
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $913K | ﹤0.01% |
24,925
-71,434
| -74% | -$2.59M |
2013 Q2
1 quarter
|
|
|
3087
Henry Schein
HSIC
$9.46B
| $912K | ﹤0.01% |
22,420
+2,533
| +13% | +$103K |
2013 Q2
1 quarter
|
|
|
GNC
3088
CALL
DELISTED
GNC Holdings, Inc.
GNC
| $912K | ﹤0.01% |
16,700
-24,800
| -60% | -$1.27M |
2013 Q2
1 quarter
|
|
|
MAKO
3089
PUT
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $912K | ﹤0.01% |
30,900
+4,700
| +18% | +$71.6K |
2013 Q2
1 quarter
|
|
3090
BlackBerry
BB
$5.46B
| $911K | ﹤0.01% |
114,645
-397,196
| -78% | -$3.86M |
2013 Q2
1 quarter
|
|
3091
Ternium
TX
$11.1B
| $911K | ﹤0.01% |
+37,950
| New | +$899K |
2013 Q3
0 quarters
|
|
3092
PUT
TechnipFMC
FTI
$27B
| $909K | ﹤0.01% |
22,042
-9,542
| -30% | -$392K |
2013 Q2
1 quarter
|
|
|
GRP.U
3093
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $909K | ﹤0.01% |
25,508
-26,978
| -51% | -$935K |
2013 Q2
1 quarter
|
|
|
FRAN
3094
CALL
DELISTED
Francesca's Holdings Corporation
FRAN
| $908K | ﹤0.01% |
4,058
-1,175
| -22% | -$337K |
2013 Q2
1 quarter
|
|
3095
Benchmark Electronics
BHE
$3.14B
| $907K | ﹤0.01% |
39,618
+5,003
| +14% | +$111K |
2013 Q2
1 quarter
|
|
3096
Unisys
UIS
$166M
| $906K | ﹤0.01% |
36,012
+34,045
| +1,731% | +$854K |
2013 Q2
1 quarter
|
|
|
3097
PUT
KeyCorp
KEY
$21.4B
| $905K | ﹤0.01% |
79,400
-38,400
| -33% | -$459K |
2013 Q2
1 quarter
|
|
|
NXTM
3098
DELISTED
NxStage Medical Inc.
NXTM
| $905K | ﹤0.01% |
68,808
+5,289
| +8% | +$69.4K |
2013 Q2
1 quarter
|
|
3099
SunCoke Energy
SXC
$840M
| $904K | ﹤0.01% |
53,192
+20,609
| +63% | +$328K |
2013 Q2
1 quarter
|
|
3100
UGI
UGI
$7.98B
| $903K | ﹤0.01% |
34,604
+5,799
| +20% | +$155K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.